Stork, Theresa
Hegedüs, Balazs
Guder, Wiebke
Hamacher, Rainer
Hardes, Jendrik
Kaths, Moritz
Plönes, Till
Pöttgen, Christoph
Schildhaus, Hans-Ulrich
Streitbürger, Arne
Treckmann, Juergen
Bauer, Sebastian
Aigner, Clemens http://orcid.org/0000-0002-7787-991X
Collaud, Stéphane
Funding for this research was provided by:
Universität Duisburg-Essen
Article History
Received: 15 February 2022
Accepted: 6 March 2022
First Online: 12 May 2022
Disclosures
: Sebastian Bauer is a consultant for Blueprint Medicine, Deciphera, Adcendio, Bayer, Boehringer, Ingelheim, Daiichi Sankyo, GSK, Exelixis, Novartis, and Cogent. The remaining authors have no conflicts of interest. Prof. Bauer received financial support for continuous medical education (CME) through Pharmamar.